Security
Aptorum Group Limited Class A Ordinary Shares · APM
APMNASDAQCommon stockHistorical · closed Jul 17, 2026CIK 1734005Updated Oct 22, 2026
Name history
Aptorum Group Ltd · through Jun 22, 2026
Current security for this SEC filerNIKI · NASDAQ
APM price & chart
Historical security
This listing closed Jul 17, 2026. Live provider charts are shown only for current listings.
Current security: NIKI
About the company
Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. For more information, please visit the company’s website at www.aptorumgroup.com.
In the news
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency ↗
Recent filings
4 filing
4 filing
4 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
EFFECT filing
Show 5 more recent filings
Entry into a Material Definitive Agreement
Items 1.01, 9.01
424B5 filing
S-3/A filing
S-3/A filing
Other Events
Items 8.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| AssetsUSD | 17,578,751Source | 18,104,586Source | 17,704,765Source | 14,412,041Source | 24,018,545Source | 31,714,867Source | 23,309,075Source | 18,691,370Source | 16,130,223Source | 20,640,091Source | 20,867,371Source |
| Property, Plant and EquipmentUSD | — | — | — | 2,190,146Source | 3,331,498Source | 4,148,449Source | 6,140,602Source | — | — | 1,663,926Source | 2,825,059Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | — | — | 166,566Source | 826,184Source | 917,170Source | 1,220,650Source | — | — | 147,347Source | 752,705Source |
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | — | 340,306Source | 4,065,788Source | — | 4,019,324Source | 3,452,891Source | — | — | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | 21,800Source | 66,396Source | 71,814Source | 47,093Source | 41,696Source | — | — | 47,709Source | 174,426Source |
| Inventory, NetUSD | — | — | — | — | 29,704Source | 32,785Source | 34,318Source | — | — | — | 27,722Source |
| Assets, CurrentUSD | 2,479,905Source | 3,005,740Source | 1,534,096Source | 1,897,991Source | 9,324,572Source | 21,918,114Source | 6,128,019Source | 3,592,524Source | 959,554Source | 2,476,092Source | 7,067,802Source |
| Prepaid Expense and Other Assets, CurrentUSD | 207,294Source | 248,846Source | 725,616Source | — | — | — | — | 139,633Source | 85,316Source | 422,071Source | 744,008Source |
| Operating Lease, Right-of-Use AssetUSD | — | — | — | 311,639Source | 495,415Source | 355,202Source | 705,890Source | — | — | 182,057Source | 347,000Source |
| LIABILITIES AND EQUITY | |||||||||||
| LiabilitiesUSD | 4,416,347Source | 4,335,942Source | 4,527,778Source | 1,632,564Source | 8,369,569Source | 5,244,525Source | 5,786,690Source | 4,899,823Source | 4,353,162Source | 5,256,738Source | 13,034,066Source |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, IssuedUSD | — | — | — | — | 13,265,503Source | 13,170,374Source | 7,950,986Source | — | — | — | 13,269,528Source |
| Additional Paid in CapitalUSD | — | — | — | 92,641,521Source | 44,336,942Source | 42,441,471Source | 33,184,104Source | — | — | 93,018,528Source | 45,308,080Source |
| Retained Earnings (Accumulated Deficit)USD | -73,485,303Source | -72,871,308Source | -70,805,518Source | -70,824,179Source | -57,422,767Source | -46,570,550Source | -43,760,545Source | -73,792,798Source | -72,429,528Source | -68,161,722Source | -65,337,075Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -158,805Source | -169,160Source | -9,762Source | 26,322Source | 29,327Source | 28,267Source | 25,618Source | -92,310Source | 89,162Source | -10,623Source | 33,807Source |
| Stockholders' Equity Attributable to ParentUSD | 22,529,972Source | 23,133,612Source | 22,654,961Source | 21,843,717Source | 22,646,759Source | 31,507,316Source | 19,837,917Source | 23,115,160Source | 21,134,514Source | 24,846,236Source | 15,712,094Source |
| Additional Paid in Capital, Common StockUSD | 96,174,010Source | 96,174,010Source | 93,470,186Source | — | — | — | — | 97,000,188Source | 93,474,825Source | — | — |
| Liabilities and EquityUSD | 17,578,751Source | 18,104,586Source | 17,704,765Source | 14,412,041Source | 24,018,545Source | 31,714,867Source | 23,309,075Source | 18,691,370Source | 16,130,223Source | 20,640,091Source | 20,867,371Source |
| Current liabilities: | |||||||||||
| Liabilities, CurrentUSD | 4,416,347Source | 1,007,442Source | 1,316,560Source | 1,433,488Source | 8,205,663Source | 4,060,919Source | 3,080,408Source | 4,593,823Source | 4,338,980Source | 2,098,753Source | 12,503,282Source |
| Operating Lease, Liability, CurrentUSD | 50,972Source | 76,992Source | 89,145Source | 305,055Source | 339,649Source | 339,040Source | 419,875Source | 24,428Source | 102,225Source | 125,232Source | 310,548Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | 62,718Source | 199,076Source | 163,906Source | 63,008Source | 319,938Source | — | 14,182Source | 99,485Source | 30,784Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -9,367,568Source | -9,364,968Source | -9,477,974Source | -9,064,240Source | -6,997,783Source | -5,036,974Source | -2,315,532Source | -9,370,613Source | -9,357,453Source | -9,462,883Source | -7,878,789Source |
| Additional Financial Items | |||||||||||
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | — | — | 295,891Source | 296,225Source | 335,878Source | — | — | — | 129,847Source |
| Other Assets, Noncurrent | — | — | — | — | — | — | —Source | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -1,376,430Source | -4,157,737Source | -4,340,975Source | -11,525,102Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | — | — | — | 255,046Source | 1,125,254Source | 1,207,510Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 1,265,189Source | 1,646,999Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | — | — | — | -41,349Source | -126,717Source | 95,704Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | — | — | — | — | -14,516Source | -8,053Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | — | — | -1,836,546Source | -1,189,734Source | -7,724,364Source | -12,318,965Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | — | 58,621Source | 624,767Source | 2,444,896Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | — | — | 3,015Source | 186,916Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | — | — | 4,415,199Source | — | 4,092,068Source | 6,625,462Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | — | — | — | — | — | -3,248,607Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 2,272,611Source | 754,592Source | 2,756,894Source | 783,085Source | 470,641Source | 7,196,058Source | 3,452,891Source | 874,238Source | 2,005,351Source | 5,012,880Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | 94,108Source | 64,744Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | 19,219Source | 84,020Source | — |
| DepreciationUSD | — | — | — | — | — | — | — | — | — | 235,827Source | 1,041,234Source | 1,092,957Source |
| Equity Method Investment, Other than Temporary ImpairmentUSD | — | — | — | — | — | — | — | — | — | — | 77,200Source | — |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | — | — | — | — | — | — | 58,621Source | — | — |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | — | — | — | 58,621Source | — | — |
| Gain (Loss) on Disposition of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | — | — | -205,189Source |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | — | -1,000,000Source | -9,266Source | -134,134Source |
| Gain (Loss) on Sale of InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | 6,353,888Source | 5,588,051Source |
| General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | 573,059Source | 669,486Source | 1,930,637Source | 5,220,405Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | — | 750,381Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | — | -1,376,430Source | — | — | — |
| Inventory Write-downUSD | — | — | — | — | — | — | — | — | — | — | 13,206Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | — | — | — | — | — | — | -1,363,270Source | -4,267,806Source | -2,824,647Source | -11,525,102Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -13,160Source | 110,069Source | -1,516,328Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | -1,363,270Source | -4,267,806Source | -2,824,647Source | -9,799,560Source |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | 441,098Source | -217,196Source | 6,383,276Source | 5,984,011Source |
| Operating Costs and ExpensesUSD | — | — | — | — | — | — | — | — | 1,817,528Source | — | — | — |
| Operating ExpensesUSD | — | — | — | — | — | — | — | — | — | — | 31,030Source | 18,805,002Source |
| Operating Lease, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 144,051Source | 200,916Source | — |
| Other Operating Income (Expense), NetUSD | — | — | — | — | — | — | — | — | 170,756Source | — | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 3,070,000Source | — | 1,575,562Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | 16,506Source | 169,460Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | 6,353,888Source | — |
| Gain (Loss) on Disposition of Other Assets | — | — | — | — | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | — | — | — | — | 431,378Source | — |
| Cost of Goods and Services Sold | — | — | — | — | — | — | —Source | — |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | -1,376,430Source | — | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | -13,160Source | 110,069Source | -1,516,328Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | — | — | -1,363,270Source | -4,267,806Source | -2,824,647Source | -11,525,102Source |
| Earnings Per Share, BasicUSD per share | — | — | — | — | -0.19Source | -0.78Source | -0.62Source | -2.75Source |
| Earnings Per Share, DilutedUSD per share | — | — | — | — | -0.19Source | -0.78Source | -0.62Source | -2.75Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | — | — | 7,351,784Source | 5,453,103Source | 4,521,133Source | 3,569,484Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | — | — | 7,351,784Source | 5,453,103Source | 4,521,133Source | 3,569,484Source |
| Additional Financial Items | ||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | 19,219Source | 84,020Source | — |
| Costs and ExpensesUSD | — | — | — | — | — | 3,940,541Source | 11,155,629Source | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | 255,046Source | — | — |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | -1,000,000Source | -9,266Source | -134,134Source |
| General and Administrative ExpenseUSD | — | — | — | — | 573,059Source | 669,486Source | 1,930,637Source | 5,220,405Source |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | — | — | — | — | — | -11,525,102Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | -1,376,430Source | — | — | — |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | — | — | -95,713Source | -146,924Source | -121,145Source | 146,588Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | -1,363,270Source | -4,267,806Source | -2,824,647Source | -9,799,560Source |
| Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, RedeemableUSD | — | — | — | — | — | — | — | 1,725,542Source |
| Nonoperating Income (Expense)USD | — | — | — | — | 441,098Source | -217,196Source | 6,383,276Source | 5,984,011Source |
| Operating Costs and ExpensesUSD | — | — | — | — | 1,817,528Source | — | — | — |
| Operating ExpensesUSD | — | — | — | — | — | — | 31,030Source | 18,805,002Source |
| Other Cost and Expense, OperatingUSD | — | — | — | — | — | 272,609Source | 1,067,690Source | — |
| Other ExpensesUSD | — | — | — | — | — | — | — | 261,038Source |
| Other Operating Income (Expense), NetUSD | — | — | — | — | 170,756Source | — | — | — |
| Research and Development ExpenseUSD | — | — | — | — | 352,879Source | 2,195,161Source | 5,198,329Source | 9,219,595Source |
| Utilities Operating Expense, Maintenance, Operations, and Other Costs and ExpensesUSD | — | — | — | — | — | — | 28,128Source | — |
Offerings
Registration 333-298608
Registration 333-291593
Registration 333-290742
Registration 333-292793
Filing attachments
ea030533401ex99-1.htm · 8-K · 2026-09-14
EX-99.1 2 ea030533401ex99-1.htm PRESENTATION Exhibit 99.1 Alidad Mireskandari, Ph. D. President & COO H.C. Wainwright Global Investment Conference, September 2026 NASDAQ: NIKI Forward-Looking Statements Legal Disclaimer This presentation contains summary information about Niki BioSolutions, Aptorum Group Limited and DiamiR Biosciences Corp. (collectively, the "Companies") as of the date hereof. The information in this presentation is of general background and contains an overview and summa…
Read attachment ↗ea030223901ex4-6.htm · S-3 · 2026-08-28
Exhibit 4.6 Niki BioSOLUTIONS, INC.c Issuer AND [TRUSTEE] Trustee INDENTURE Dated as of [●], 20[●] Senior Debt Securities TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 Section …
Read attachment ↗ea030223901ex4-7.htm · S-3 · 2026-08-28
Exhibit 4.7 NIKI BIOSOLUTIONS, INC. Issuer AND [TRUSTEE] Trustee INDENTURE Dated as of [●], 20[●] Subordinated Debt Securities TABLE OF CONTENTS ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms. 1 ART…
Read attachment ↗ea030180301ex99-1.htm · 8-K/A · 2026-08-21
EX-99.1 3 ea030180301ex99-1.htm AUDITED FINANCIAL STATEMENTS OF DIAMIR AS OF MAY 31, 2026 AND 2025 AND FOR THE YEARS THEN ENDED Exhibit 99.1 Report of Independent Registered Public Accounting Firm To the Stockholders and Board of Directors of DiamiR Biosciences Corp. Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of DiamiR Biosciences Corp. (the “Company”) as of May 31, 2026 and 2025, the related consolidated statements of operations, st…
Read attachment ↗ea030180301ex99-2.htm · 8-K/A · 2026-08-21
EX-99.2 4 ea030180301ex99-2.htm UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS AND THE RELATED NOTES THERETO Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On July 20, 2026 (the “Closing Date”), after obtaining the requisite shareholder approval and satisfying the closing conditions, Aptorum Group Limited (“Aptorum”) consummated its previously announced merger (the “Closing”) pursuant to that certain Agreement and Plan of Merger dated July 14, 2025 (…
Read attachment ↗ea030254401ex99-1.htm · 8-K · 2026-08-21
EX-99.1 2 ea030254401ex99-1.htm UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2026 AND DECEMBER 31, 2025, AND FOR THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025 Exhibit 99.1 Financial Statements Table of Contents Unaudited Condensed Consolidated Balance Sheets as of June 30, 2026 and December 31, 2025 F-2 Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the six months ended June…
Read attachment ↗